Alternatively, although the difference was small, siRNA-mediated knockdown of HIF-1α, but not HIF-2α, increased TRAIL sensitivity in a prostate (DU145) and a cervical cancer cell line (HeLa) (Figure 3b). Here, EPAS1 is linked to cervical cancer.